Pragna Vanapala
Family Medicine · Frederick, MDNPI 1386223022
Payments from drug & device makers
Across 46 payments — averaging $21.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$188
- Novo Nordisk$121
- AbbVie$99
- GSK$73
- Boston Scientific$52
- Astellas Pharma US Inc$52
- plus $422 from 16 others
What the payments were for
- Food & beverage$1,007100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $188 |
| Novo Nordisk | 5 | $121 |
| AbbVie | 5 | $99 |
| GSK | 4 | $73 |
| Boston Scientific | 1 | $52 |
| Astellas Pharma US Inc | 2 | $52 |
| Exact Sciences | 2 | $46 |
| Amgen | 2 | $44 |
| Pfizer | 2 | $43 |
| Lilly USA, LLC | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Baxter Healthcare | 1 | $27 |
| Dexcom, Inc. | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $23 |
| BD | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Aerin Medical Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Abbott | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Organon | 1 | $14 |
| Merck | 1 | $14 |
How this compares
$1,007 in reported general payments places this provider in the 65th percentile of 1,193 family medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 12 | $11,412 |
| MyrbetriqMirabegron | 11 | $6,031 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $475 |
| Metformin Hcl ErMetformin Hcl | 14 | $229 |
| Atorvastatin Calcium | 23 | $177 |
| Rosuvastatin Calcium | 24 | $165 |
| Pantoprazole Sodium | 16 | $134 |
| Losartan Potassium | 12 | $128 |
| Levothyroxine Sodium | 20 | $121 |
| Amlodipine Besylate | 19 | $109 |
| Sertraline Hcl | 15 | $96 |
| Benazepril Hcl | 13 | $88 |
| Montelukast Sodium | 13 | $79 |
| Hydrochlorothiazide | 14 | $78 |
| Lisinopril | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $188 | $11,41212 claims |
| Astellas Pharma US IncMyrbetriq | $52 | $6,03111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,193 family medicine providers in Maryland.
Other family medicine in Frederick
- Amreen AzizFrederick$14K
- Stephen OngOxon Hill$5.9M
- Stephan BartWoodstock$1.7M
- Karen DonaldsonBaltimore$899K
- Rajiv DuaColumbia$765K
- Greg TampusLutherville Timonium$735K
- Louis JacquesBaltimore$522K
- Stephanie MellerOxon Hill$518K
- Sharon ChungGlen Burnie$333K
- Michael ObiefuneBaltimore$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.